Endoproteolytic activity in mammalian brain membranes cleaves 5-hydroxytryptamine-moduline into dipeptides

Author： Plantefol M.   Rousselle J.C.   Bernardi E.   Schoofs A.R.   Pourrias B.   Fillion G.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.376, Iss.1, 1999-07, pp. : 109-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser

By Gobbi M.   Mennini T.  

European Journal of Pharmacology, Vol. 370, Iss. 1, 1999-04 ,pp. : 23-26

Elsevier

Access to resources Recommend Favorite

Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo

By Gur E.   Dremencov E.   Lerer B.   Newman M.E.  

European Journal of Pharmacology, Vol. 372, Iss. 1, 1999-05 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite

The effect of d-fenfluramine on brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male and female rats

By Datla K.P.   Curzon G.  

European Journal of Pharmacology, Vol. 333, Iss. 1, 1997-08 ,pp. : 27-31

Elsevier

Access to resources Recommend Favorite

Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors

By Hervas I.   Artigas F.  

European Journal of Pharmacology, Vol. 358, Iss. 1, 1998-09 ,pp. : 9-18

Elsevier

Access to resources Recommend Favorite

Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine

By Hajos-Korcsok  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 101-107

Elsevier

Access to resources Recommend Favorite